Gene · 1616
Papers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis. | BMC Cancer | 2023 | 37268925 | PubTator, text mining | PubMed |
| Metastatic insulinoma: exploration from clinicopathological signatures and genetic characteristics. | Front Oncol | 2023 | 37251916 | PubTator, text mining | PubMed |
| Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. | Front Immunol | 2023 | 37251408 | PubTator, text mining | PubMed |
| Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme. | Metab Brain Dis | 2023 | 37249862 | PubTator, text mining | PubMed |
| Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia. | Front Endocrinol (Lausanne) | 2023 | 37234805 | PubTator, text mining | PubMed |
| Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases. | Neuroendocrinology | 2023 | 37232011 | PubTator, text mining | PubMed |
| Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus. | Elife | 2023 | 37227756 | PubTator, text mining | PubMed |
| S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. | Breast Cancer Res | 2023 | 37217945 | PubTator, text mining | PubMed |
| Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. | Dis Markers | 2023 | 37215201 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy. | Explor Target Antitumor Ther | 2023 | 37205317 | PubTator, text mining | PubMed |
| SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022). | Clin Transl Oncol | 2023 | 37204633 | PubTator, text mining | PubMed |
| Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus. | J Clin Invest | 2023 | 37200088 | PubTator, text mining | PubMed |
| SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA. | Microbiol Spectr | 2023 | 37199632 | PubTator, text mining | PubMed |
| Neuroendocrine Tumors: Genomics and Molecular Biomarkers with a Focus on Metastatic Disease. | Cancers (Basel) | 2023 | 37190177 | PubTator, text mining | PubMed |
| The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer. | Cancers (Basel) | 2023 | 37190157 | PubTator, text mining | PubMed |
| Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis. | Sci Rep | 2023 | 37185778 | PubTator, text mining | PubMed |
| Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. | Endocr Relat Cancer | 2023 | 37184955 | PubTator, text mining | PubMed |
| Genome-wide analysis of RNA-binding proteins co-expression with alternative splicing events in mitral valve prolapse. | Front Immunol | 2023 | 37180137 | PubTator, text mining | PubMed |
| Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer's Disease. | Int J Mol Sci | 2023 | 37175659 | PubTator, text mining | PubMed |
| Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). | Diagnostics (Basel) | 2023 | 37174986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1616/papers?page=19